Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Characterization of aberrant phenotypes in acute myeloblastic leukemia.

Annals of hematology - 1 Apr 1995

Macedo A, Orfão A, Vidriales M B, López-Berges M C, Valverde B, González M, Caballero M D, Ramos F, Martínez M, Fernández-Calvo J

Abstract excerpt

The existence of leukemic-associated phenotypes has been suggested to be a valuable tool for the detection of minimal residual disease (MRD) in AML patients, as they would allow to distinguish leukemic blast cells from normal hematopoietic progenitors. The present study was designed to analyze in which proportion of AML patients the immunological detection of MRD is feasible, based on the presence of aberrant...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies, Monoclonal
Share to Antigens, CD

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Flow Cytometry

Share to HLA-DR Antigens

Share to Immunophenotyping

Share to Leukemia, Myeloid, Acute

Share to Phenotype

Source

Identifiers

PMID: 7748963
DOI: 10.1007/BF01700374

Genes

CD14
CD34
CD33
CD19
CD2
CD4
CD5
CD7

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Characterization of aberrant phenotypes in acute myeloblastic leukemia.PMID 7748963Read ↗

Leukemia-associated phenotypes: their characteristics and incidence in acute leukemia.Semantic proximity Read ↗

Immunological detection of blast cell subpopulations in acute myeloblastic leukemia at diagnosis: implications for minimal residual disease studies.Semantic proximity Read ↗

Immunophenotypical profiling of myeloid neoplasms with erythroid predominance using mass cytometry ( CyTOF )Semantic proximity Read ↗

Expression of aberrant CD markers in acute leukemia: A study of 100 cases with immunophenotyping by multiparameter flowcytometrySemantic proximity Read ↗

Expression of unusual immunophenotype combinations in acute myelogenous leukemiaSemantic proximity Read ↗

Characterization of flow cytometric immuno-phenotyping of acute myeloid leukemia with minimal differentiation and acute T-cell lymphoblastic leukemia: A retrospective cross-sectional studySemantic proximity Read ↗

Expression of unusual immunophenotype combinations in acute myelogenous leukemiaSemantic proximity Read ↗

Aberrant Phenotype in Acute Myeloid Leukemia: Hematology Laboratory Experiment of the University Hospital of Casablanca, Morocco.Semantic proximity Read ↗

Multiparameter flow cytometry applications in the diagnosis of mixed phenotype acute leukemiaSemantic proximity Read ↗

Phenotypic changes in acute myeloid leukaemia: implications in the detection of minimal residual disease.Semantic proximity Read ↗

The impact of cell heterogeneity and immunophenotypic changes on monitoring minimal residual disease in acute myeloid leukemia.Semantic proximity Read ↗

Immunophenotypic portrait of leukemia‐associated‐phenotype markers in B acute lymphoblastic leukemiaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.